Glimisave M1 Forte Tablet PR
By Glimisave M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(1000mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
September, 2027

liver
When using Glimisave M1 Forte Tablet PR, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication. It is advisable to consult your doctor before starting treatment with Glimisave M1 Forte Tablet PR. Typically, this medication is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease.

kidney
Glimisave M1 Forte Tablet PR needs caution in kidney disease. Dosage adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during use. Consulting your doctor is essential.

alcohol
It is not recommended to drink alcohol while taking Glimisave M1 Forte Tablet PR. Please avoid alcohol consumption with this medication. Caution should be taken during pregnancy.

driving
Driving while taking Glimisave M1 Forte Tablet PR can be risky if your blood sugar is too low or high. Avoid driving if you have these symptoms to ensure safety.

pregnancy
Glimisave M1 Forte Tablet PR may not be safe to use during pregnancy. Limited human studies and animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing it. Please consult your doctor.

breastfeeding
Caution should be exercised during breastfeeding as Glimisave M1 Forte Tablet PR is not recommended. It may pose a risk of toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹166.01
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024